Annual EBITDA
-$40.01 M
+$34.20 M+46.09%
December 31, 2022
Summary
- As of February 10, 2025, SGTX annual EBITDA is -$40.01 million, with the most recent change of +$34.20 million (+46.09%) on December 31, 2022.
- During the last 3 years, SGTX annual EBITDA has risen by +$2.59 million (+6.09%).
Performance
SGTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$6.89 M
-$434.00 K-6.73%
June 30, 2023
Summary
- As of February 10, 2025, SGTX quarterly EBITDA is -$6.89 million, with the most recent change of -$434.00 thousand (-6.73%) on June 30, 2023.
- Over the past year, SGTX quarterly EBITDA has increased by +$6.60 million (+48.94%).
Performance
SGTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$26.81 M
+$6.60 M+19.76%
June 30, 2023
Summary
- As of February 10, 2025, SGTX TTM EBITDA is -$26.81 million, with the most recent change of +$6.60 million (+19.76%) on June 30, 2023.
- Over the past year, SGTX TTM EBITDA has increased by +$36.02 million (+57.33%).
Performance
SGTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SGTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.1% | +48.9% | +57.3% |
| 3 y3 years | +6.1% | +47.4% | +32.6% |
| 5 y5 years | -81.0% | +52.0% | -86.8% |
SGTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.5% | +20.4% | +145.9% | at high | +176.8% |
| 5 y | 5-year | at high | +85.5% | +20.4% | +185.8% | +86.8% | +176.8% |
| alltime | all time | +81.0% | +85.5% | +20.4% | +185.8% | +86.8% | +176.8% |
Sigilon Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$6.89 M(+6.7%) | -$26.81 M(-19.8%) |
| Mar 2023 | - | -$6.45 M(+12.8%) | -$33.41 M(-16.5%) |
| Dec 2022 | -$40.01 M(-46.1%) | -$5.72 M(-26.2%) | -$40.01 M(-21.9%) |
| Sep 2022 | - | -$7.75 M(-42.5%) | -$51.22 M(-18.5%) |
| Jun 2022 | - | -$13.49 M(+3.3%) | -$62.83 M(-9.0%) |
| Mar 2022 | - | -$13.05 M(-22.9%) | -$69.02 M(-7.0%) |
| Dec 2021 | -$74.20 M | -$16.94 M(-12.5%) | -$74.20 M(+3.5%) |
| Sep 2021 | - | -$19.35 M(-1.7%) | -$71.73 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$19.68 M(+7.9%) | -$65.06 M(+11.3%) |
| Mar 2021 | - | -$18.24 M(+26.1%) | -$58.47 M(+11.3%) |
| Dec 2020 | -$52.55 M(+23.4%) | -$14.46 M(+14.0%) | -$52.55 M(+0.2%) |
| Sep 2020 | - | -$12.68 M(-3.1%) | -$52.45 M(+31.9%) |
| Jun 2020 | - | -$13.09 M(+6.2%) | -$39.76 M(+49.1%) |
| Mar 2020 | - | -$12.32 M(-14.1%) | -$26.68 M(+85.9%) |
| Dec 2019 | -$42.60 M(+92.7%) | -$14.35 M | -$14.35 M |
| Dec 2018 | -$22.10 M | - | - |
FAQ
- What is Sigilon Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Sigilon Therapeutics?
- What is Sigilon Therapeutics annual EBITDA year-on-year change?
- What is Sigilon Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Sigilon Therapeutics?
- What is Sigilon Therapeutics quarterly EBITDA year-on-year change?
- What is Sigilon Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Sigilon Therapeutics?
- What is Sigilon Therapeutics TTM EBITDA year-on-year change?
What is Sigilon Therapeutics annual EBITDA?
The current annual EBITDA of SGTX is -$40.01 M
What is the all time high annual EBITDA for Sigilon Therapeutics?
Sigilon Therapeutics all-time high annual EBITDA is -$22.10 M
What is Sigilon Therapeutics annual EBITDA year-on-year change?
Over the past year, SGTX annual EBITDA has changed by +$34.20 M (+46.09%)
What is Sigilon Therapeutics quarterly EBITDA?
The current quarterly EBITDA of SGTX is -$6.89 M
What is the all time high quarterly EBITDA for Sigilon Therapeutics?
Sigilon Therapeutics all-time high quarterly EBITDA is -$5.72 M
What is Sigilon Therapeutics quarterly EBITDA year-on-year change?
Over the past year, SGTX quarterly EBITDA has changed by +$6.60 M (+48.94%)
What is Sigilon Therapeutics TTM EBITDA?
The current TTM EBITDA of SGTX is -$26.81 M
What is the all time high TTM EBITDA for Sigilon Therapeutics?
Sigilon Therapeutics all-time high TTM EBITDA is -$14.35 M
What is Sigilon Therapeutics TTM EBITDA year-on-year change?
Over the past year, SGTX TTM EBITDA has changed by +$36.02 M (+57.33%)